Literature DB >> 23686358

Exact inference for adaptive group sequential designs.

Ping Gao1, Lingyun Liu, Cyrus Mehta.   

Abstract

Methods for controlling the type-1 error of an adaptive group sequential trial were developed in seminal papers by Cui, Hung, and Wang (Biometrics, 1999), Lehmacher and Wassmer (Biometrics, 1999), and Müller and Schäfer (Biometrics, 2001). However, corresponding solutions for the equally important and related problem of parameter estimation at the end of the adaptive trial have not been completely satisfactory. In this paper, a method is provided for computing a two-sided confidence interval having exact coverage, along with a point estimate that is median unbiased for the primary efficacy parameter in a two-arm adaptive group sequential design. The possible adaptations are not only confined to sample size alterations but also include data-dependent changes in the number and spacing of interim looks and changes in the error spending function. The procedure is based on mapping the final test statistic obtained in the modified trial into a corresponding backward image in the original trial. This is an advance on previously available methods, which either produced conservative coverage and no point estimates or provided exact coverage for one-sided intervals only.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  adaptive median unbiased estimates; estimation in adaptive design; exact adaptive confidence intervals; group sequential estimation

Mesh:

Year:  2013        PMID: 23686358     DOI: 10.1002/sim.5847

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

2.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

3.  ANALYSIS OF "LEARN-AS-YOU-GO" (LAGO) STUDIES.

Authors:  Daniel Nevo; Judith J Lok; Donna Spiegelman
Journal:  Ann Stat       Date:  2021-04-02       Impact factor: 4.904

4.  Adaptive designs in clinical trials: why use them, and how to run and report them.

Authors:  Philip Pallmann; Alun W Bedding; Babak Choodari-Oskooei; Munyaradzi Dimairo; Laura Flight; Lisa V Hampson; Jane Holmes; Adrian P Mander; Lang'o Odondi; Matthew R Sydes; Sofía S Villar; James M S Wason; Christopher J Weir; Graham M Wheeler; Christina Yap; Thomas Jaki
Journal:  BMC Med       Date:  2018-02-28       Impact factor: 8.775

5.  The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  Trials       Date:  2020-06-17       Impact factor: 2.279

6.  Estimation of treatment effects following a sequential trial of multiple treatments.

Authors:  John Whitehead; Yasin Desai; Thomas Jaki
Journal:  Stat Med       Date:  2020-03-23       Impact factor: 2.373

7.  Adaptive multiarm multistage clinical trials.

Authors:  Pranab Ghosh; Lingyun Liu; Cyrus Mehta
Journal:  Stat Med       Date:  2020-02-11       Impact factor: 2.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.